Fund Holdings — Omega Fund Management, LLC

Total Portfolio Value:
$123.44M
Total Bought:
$39.80M
Total Sold:
$1.76M
Net Transaction:
+$38.04M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Lexeo Therapeutics, Inc.(LXEO)02,157,623+2,157,623$0$28.96M23.46%+$28.96M
Replimune Group, Inc.(REPL)3,001,3193,001,3190$51.35M$25.30M20.50%-$26.05M
Nuvation Bio Inc.CL A(NUVB)15,072,34015,072,3400$20.20M$22.76M18.44%+$2.56M
enGene Holdings Inc.
COM
01,131,175+1,131,175$0$10.44M8.46%+$10.44M
Morphic Holding309,846309,8460$7.10M$8.95M7.25%+$1.85M
Spruce Biosciences2,161,0222,161,0220$4.88M$6.33M5.13%+$1.45M
Kronos Bio3,818,2833,818,2830$4.96M$4.77M3.87%-$190.9K
Ikena Oncology2,249,1232,249,1230$9.74M$4.43M3.59%-$5.31M
Sana Biotechnology, Inc.(SANA)843,750843,7500$3.27M$3.44M2.79%+$177.2K
Theseus Pharmaceuticals711,479711,4790$1.91M$2.88M2.33%+$967.6K
Immunic, Inc.(IMUX)1,788,1601,788,1600$2.63M$2.68M2.17%+$53.6K
Syros Pharmaceuticals251,270251,2700$992.5K$1.96M1.59%+$964.9K
enGene Holdings Inc.WARRANT
*W EXP 10/31/202
0475,077+475,077$0$403.8K0.33%+$403.8K
Senti Biosciences, Inc.195,792195,7920$80.9K$129.2K0.10%+$48.4K
Alpine Immune SciencesCommon Stock153,7000-153,700$1.76M$0—-$1.76M
Page 1 of 1
Omega Fund Management, LLC — 13F Holdings — Q4 2023 | TickerTrail